Abimiku Alash'le G
Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Am J Clin Pathol. 2009 Jun;131(6):875-86. doi: 10.1309/AJCPELMG6GX6RQSM.
An unprecedented influx of funds and support through large programs such as the Global Fund for AIDS, Malaria and Tuberculosis and the World Health Organization's and President's Emergency Plan for AIDS Relief (PEPFAR) has made it possible for more than 1 million persons in resource-limited settings to access AIDS treatment and several million more to be in care and prevention programs. Nevertheless, there remain major challenges that prevent AIDS drugs and care from reaching many more in need, especially in rural settings. The roll-out of a high-quality treatment, care, and prevention program depends on an effective and reliable laboratory infrastructure. This article presents a strategy used by the Institute of Human Virology (IHV)-University of Maryland and its affiliate IHV-Nigeria to establish a multifaceted, integrated tier laboratory program to support a PEPFAR-funded scale-up of its AIDS Care Treatment in Nigeria program, in collaboration with the Centers for Disease Control and Prevention and the Nigerian government, as a possible model for overcoming a key challenge that faces several resource-limited countries trying to roll out and scale-up their HIV/AIDS treatment, care, and prevention program.
通过诸如全球防治艾滋病、结核病和疟疾基金以及世界卫生组织的总统艾滋病紧急救援计划(PEPFAR)等大型项目,前所未有的资金和支持涌入,使得资源有限地区的100多万人能够获得艾滋病治疗,还有数百万人能够参与护理和预防项目。然而,仍然存在重大挑战,阻碍艾滋病药物和护理惠及更多有需要的人,特别是在农村地区。高质量治疗、护理和预防项目的推广依赖于有效且可靠的实验室基础设施。本文介绍了马里兰大学人类病毒学研究所(IHV)及其附属机构尼日利亚IHV所采用的一项策略,即与疾病控制和预防中心以及尼日利亚政府合作,建立一个多层面、综合的分级实验室项目,以支持其在尼日利亚的由PEPFAR资助的艾滋病护理治疗项目扩大规模,作为克服几个资源有限国家在试图推广和扩大其艾滋病毒/艾滋病治疗、护理和预防项目时面临的一项关键挑战的可能模式。
Afr J Med Med Sci. 2010-9
Am J Clin Pathol. 2010-10
Nat Commun. 2024-11-9
J Clin Lab Anal. 2021-6